Objective: Clozapine has been found to be superior to typical neuroleptics
in ameliorating the symptoms of refractory schizophrenia. This study evalua
ted clozapine's effect on the rate of death due to suicide.
Method: All patients over a 4-year period who initiated treatment with cloz
apine while hospitalized within the Department of Veterans Affairs (VA) sys
tem (N=1,415) were matched with a schizophrenic control group (N=2,830) by
propensity scoring-a widely accepted statistical method that has been used
relatively little in psychiatric research. Centralized VA databases and a n
ational death registry were used to identify all deaths within the two grou
ps, along with listed causes, for the 3 years after discharge.
Results: Veterans exposed to clozapine while inpatients were significantly
less likely to die during the follow-up period than those in the control gr
oup, but this was entirely attributable to the much lower rate of death due
to respiratory disorders in the clozapine group. There were no significant
differences in rates of suicide or accidental death.
Conclusions: These results fail to support the hypothesis that clozapine tr
eatment is associated with significantly fewer deaths due to suicide.